Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.7453 per EA under NDC 00904720906. Its NADAC has been published 70 times since Feb 26, 2025.
Strength
800 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904720906
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
PARENTERAL
Last Updated
6/17/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204724On Market Since
8/19/2024
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 70 times since Feb 26, 2025, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7453 per EA |
|---|---|
| All-time high | $1.3679 (Sep 10, 2025) |
| All-time low | $0.7453 (Jun 17, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7453 |
| Median price | $1.1464 |
| Average price | $1.1143 |
| Largest weekly change | -11.4% (Nov 19, 2025) |
| Weeks tracked | 70 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Major Pharmaceuticals, is $0.7453 per EA (NDC 00904720906), effective Jun 24, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 42.3%. It has been tracked across 70 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Feb 26, 2025, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7453 (Jun 17, 2026) to a high of $1.3679 (Sep 10, 2025), with a median of $1.1464 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SEVELAMER HCL 800 MG TABLET, but none are currently priced below it.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 00904720906) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification